Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05025748 · ClinicalTrials.gov registry record · NA
Ask Questions (ASQ):Implementation of a Communication Intervention
A NA study of Stage IV Breast Cancer and Stage II Breast Cancer, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 8
- Study locations
NCT05025748 is a NA study of Stage IV Breast Cancer and Stage II Breast Cancer that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 81 participants, above the 64-participant average among 30 other Stage IV Breast Cancer trials with a reported enrollment target (27% higher). The trial reports 8 study locations across 1 state.
The verdict
NCT05025748, a NA study of Stage IV Breast Cancer and Stage II Breast Cancer, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 8
- Study locations
Study Summary
This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and patients' family want to ask the doctor.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Intervention
Study Locations (8)
Michigan
- Karmanos Cancer Institute at McLaren Bay Region - Bay City
- Karmanos Cancer Institute at McLaren Clarkston - Clarkston
- Karmanos Cancer Institute - Detroit
- Karmanos Cancer Institute at McLaren Flint - Flint
- Karmanos Cancer Institute at McLaren Macomb - Mount Clemens
- Karmanos Cancer Institute at McLaren Central Michigan - Mount Pleasant
- Karmanos Cancer Institute at McLaren Northern Michigan - Petoskey
- Karmanos Cancer Institute at McLaren Port Huron - Port Huron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2021-08-25 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05025748
The ClinicalTrials.gov registry entry for NCT05025748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 64-participant average among 30 other Stage IV Breast Cancer trials with a reported enrollment target (27% higher). The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Stage IV Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Intervention is the first listed.
NCT05025748 reports 8 study locations spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05025748 about?
NCT05025748 is a clinical study titled "Ask Questions (ASQ):Implementation of a Communication Intervention". This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and pati...
What is the current status of trial NCT05025748?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2021-08-25. Estimated completion is 2022-08-31.
What conditions does trial NCT05025748 study?
This clinical trial studies the following conditions: Stage IV Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Lung Cancer, Stage II Prostate Cancer.
What interventions are being tested in trial NCT05025748?
The interventions under investigation include: Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05025748?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05025748 being conducted?
This trial has 8 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IV Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
RECRUITING · NA
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
-
Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
-
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
COMPLETED · NA
-
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
COMPLETED · NA
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.